*Health-Related Quality of Life and disease-specific symptoms among Lymphoma and Multiple Myeloma survivors: A longitudinal PROFILES registry study. VITA-study*

Recruiting

• Conditions: Lymphoma; Multiple Myeloma; 10025322

• Registration Number: NL-OMON52363
• Lead Sponsor: Integraal Kankercentrum Nederland (IKNL)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 560

Inclusion Criteria

In order to be eligible to participate in this study, a subject must meet all
of the following criteria:
- Patients diagnosed with either HL, NHL, CLL or MM
- 18 years or older
- Able to fill out questionnaires Dutch (in terms of language skills and
cognitive abilities).

Exclusion Criteria

Patients with severe psychopathology or dementia, and patients in transition to
terminal care will be excluded from the study. We will only have our
questionnaire in Dutch, so patients who cannot read Dutch will be unable to
complete the questionnaire.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary: HRQoL (EORTC QLQ-C30) and disease specific HRQoL/symptoms (EORTC<br /><br>QLQ-LYMPH32 or EORTC QLQ-MY20 + 2 single items from EORTC item library)</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary: neuropathy (single item from EORTC item library), sexual<br /><br>functioning/intimacy (5 single items from EORTC item library), anxiety and<br /><br>depressive symptoms (HADS), side effects (PRO-CTC-AE), personality (LOT-R and<br /><br>BFI), self-management (HEIQ), coping (SE7), health status (EQ-5D), therapy<br /><br>adherence (MARS) and health-care use.</p><br>